Treatment strategies for progressive immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome: case seriesJack J. Scala, Nirali N. Shah, Michael J. Eckrich et al.|Haematologica|2024Cited by 17
Improvements in health-related quality of life in patients with severe sickle cell disease after exagamglogene autotemcelAkshay Sharma, Haydar Frangoul, Franco Locatelli et al.|Blood Advances|2025Cited by 4
Durable Clinical Benefits with Exagamglogene Autotemcel for Severe Sickle Cell DiseaseHaydar Frangoul, Stephan A. Grupp, Franco Locatelli et al.|Blood|2024Cited by 3
Long-term follow-up demonstrates durable clinical benefits of exagamglogene autotemcel for sickle cell disease with recurrent vaso-occlusive crises: Final results of climb SCD-121Stephan A. Grupp, Haydar Frangoul, Akshay Sharma et al.|Blood|2025Cited by 1
Prevalence of and Risk Factors for Cardiac, Pulmonary, and Neurologic Dysfunction Following Hematopoietic Cell Transplant for Sickle Cell Disease: A STAR StudyElizabeth Stenger, Allistair Abraham, Deepak Chellapandian et al.|Transplantation and Cellular Therapy|2022Cited by 1